4UIW
BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 9 |
Details | BINDING SITE FOR RESIDUE EDO A 1123 |
Chain | Residue |
A | GLN37 |
A | ALA46 |
A | PHE47 |
A | GLY68 |
A | PHE118 |
A | HOH2037 |
A | HOH2039 |
A | HOH2136 |
A | HOH2223 |
site_id | AC2 |
Number of Residues | 13 |
Details | BINDING SITE FOR RESIDUE H1B A 1124 |
Chain | Residue |
A | PHE44 |
A | PHE45 |
A | VAL49 |
A | ILE53 |
A | TYR99 |
A | ASN100 |
A | ARG101 |
A | THR104 |
A | TYR106 |
A | LYS111 |
A | HOH2112 |
A | HOH2206 |
A | HOH2224 |
Functional Information from SwissProt/UniProt
site_id | SWS_FT_FI1 |
Number of Residues | 2 |
Details | SITE: Histone H4K5ac H4K8ac and histone H4K5bu H4K8bu binding => ECO:0000269|PubMed:26365797 |
Chain | Residue | Details |
A | ILE53 | |
A | TYR106 |